spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

T3: Trials, Tech and Transformation

T3_2018

30-31 May 2018
Raleigh Convention Center, Raleigh, NC

T3 is back for 2018 to provide you with the latest updates and top tips from across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma, biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to voice their questions, connect with peers, and get direct feedback from an expert speaker line-up. And this year, we're in Raleigh.

Explore:

• Paradigm Shifts in Clinical Trials: Partnerships and Collaboration, Digital Transformation, New Technology and Innovation, and The Changing Landscape

• Patients as Partners: Voice of the Patient, Recruitment and Engagement

• Clinical Research: Real-Time Data and Analytics

• Insights and Innovations from Immuno-oncology and Rare Disease

Book now to secure your place alongside leading clinical professionals on 30-31 May, ask your questions, and put yourself at the heart of the latest clinical discussions.

Download the agenda to see what we have lined up for you: https://goo.gl/cMq9qC

Visit the website to find out more: www.t3clinicalevent.com

 

phone 1 941-554-3500
email register@knect365.com
web goo.gl/VucvDb
email Raleigh Convention Center, NC
 
Print this page
Send to a friend
   
spacer
Industry Events

SMI Immuno-Oncology Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
More info >>

Banner of T3_events_97 on Samedan Banner of ChinaBio_Events_102 on Samedan

White Papers

Faster, Better, Cheaper: Lean as a Driving Force Behind Pharmaceutical Companies’ Growth

TBM Consulting Group

The pharmaceutical industry faces countless challenges: patent expirations, weak product development pipelines, downward pricing pressure and an increasingly burdensome regulatory environment. The most important question for companies is now “How can we position ourselves optimally to be successful in the long term?” Some pharmaceutical companies used the economic downturn in 2009 to embrace measures in the fields of cost reduction and efficiency increases, which can be implemented at short notice. The continuous and consistent implementation of sustainable measures that guarantee stability and form the basis for future growth was not necessarily paramount within this.
More info >>


News and Press Releases

NDA Group Releases Data Comparing FDA and EMA Ahead of Annual DIA Europe in Basel

Today NDA Group announced their findings from its fifth annual comparison of drug approvals in Europe and the United States, in preparation for this year’s DIA Europe in Basel, Switzerland. The figures highlight the continued differences between the two regions, and the need for a global approach to drug development to ensure success across both continents.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement